X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1670) 1670
Publication (128) 128
Dissertation (23) 23
Book Chapter (8) 8
Book Review (7) 7
Magazine Article (2) 2
Web Resource (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (990) 990
hbeag (840) 840
index medicus (611) 611
female (604) 604
gastroenterology & hepatology (596) 596
adult (579) 579
male (578) 578
hepatitis b (558) 558
hepatitis b virus (455) 455
middle aged (446) 446
hepatitis b, chronic - drug therapy (407) 407
hepatitis b virus - genetics (402) 402
hepatitis b e antigens - blood (375) 375
antiviral agents - therapeutic use (339) 339
chronic hepatitis b (337) 337
lamivudine (333) 333
virology (304) 304
dna, viral - blood (288) 288
hepatocellular-carcinoma (286) 286
hepatitis b, chronic - virology (264) 264
hbsag (262) 262
hbeag seroconversion (249) 249
hepatitis (247) 247
hepatitis b surface antigens - blood (243) 243
interferon (239) 239
treatment outcome (238) 238
infection (237) 237
hepatitis b virus - immunology (225) 225
adolescent (213) 213
therapy (210) 210
genotype (206) 206
natural-history (206) 206
hepatitis b, chronic - immunology (199) 199
infectious diseases (193) 193
aged (192) 192
antigens (192) 192
dna (190) 190
viral load (179) 179
seroconversion (175) 175
health aspects (168) 168
young adult (168) 168
virus diseases (162) 162
digestive system diseases (160) 160
e-antigen (160) 160
hbv (159) 159
virus-infection (158) 158
hepatitis b e antigen (157) 157
hbv dna (156) 156
alanine transaminase - blood (154) 154
hepatitis b, chronic - blood (153) 153
surface-antigen (146) 146
interferon-alpha - therapeutic use (145) 145
peginterferon alpha-2a (144) 144
entecavir (143) 143
hepatitis b virus - drug effects (138) 138
adefovir dipivoxil (135) 135
mutation (135) 135
hepatitis b e antigens - immunology (129) 129
hepatitis b - immunology (128) 128
hepatitis b surface antigen (126) 126
hepatitis b virus - isolation & purification (123) 123
lamivudine - therapeutic use (119) 119
analysis (116) 116
e-antigen seroconversion (113) 113
pharmacology & pharmacy (112) 112
cirrhosis (110) 110
liver (110) 110
child (106) 106
hepatocellular carcinoma (105) 105
hepatitis b, chronic - diagnosis (104) 104
follow-up studies (103) 103
term-follow-up (103) 103
care and treatment (102) 102
biomarkers - blood (101) 101
antiviral therapy (99) 99
antiviral agents - administration & dosage (97) 97
deoxyribonucleic acid--dna (97) 97
time factors (97) 97
hepatology (96) 96
gastroenterology and hepatology (95) 95
hepatitis b - virology (95) 95
prognosis (95) 95
risk factors (93) 93
hepatitis b e antigens - analysis (91) 91
virus (91) 91
risk (89) 89
mutations (88) 88
retrospective studies (87) 87
carriers (84) 84
guanine - analogs & derivatives (83) 83
liver cirrhosis (83) 83
management (82) 82
research (82) 82
tenofovir (82) 82
drug therapy (81) 81
drug therapy, combination (80) 80
hbv-dna (80) 80
hepatitis b virus - physiology (80) 80
polymerase chain reaction (80) 80
virological response (80) 80
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1479) 1479
Korean (103) 103
Chinese (67) 67
Japanese (15) 15
Spanish (12) 12
French (9) 9
German (3) 3
Russian (3) 3
Turkish (3) 3
Italian (2) 2
Persian (2) 2
Polish (2) 2
Czech (1) 1
Hungarian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


临床肝胆病杂志, ISSN 1001-5256, 2014, Volume 30, Issue 4, pp. 367 - 369
... 
肝功能衰竭 | 肝炎 | 血浆置换 | 乙型 | and INR between the patients with response to treatment and those without response to treatment (P<0.000 1 | total bilirubin | prealbumin (PA) | and INR were drawn | cholinesterase | AFP | and P<0.000 1). The receiver operating characteristic (ROC) curves of PA | and alpha-fetoprotein (AFP). Comparison between two groups was made by chi-square test or non-parametric test. ResultsThere was no significant difference in treatment outcome between the HBeAg-negative cases and HBeAg-positive cases (P=0.158). There were significant differences in PA | 0.795 | respectively. ConclusionThere is no significant difference in treatment outcome between HBeAg-positive and HBeAg-negative patients with HBV-related ACLF treated with ALSS. PA | P=0.000 5 | accurate prognostic evaluation of HBV-related ACLF. MethodsA retrospective analysis was performed on the clinical data of 81 patients with HBV-related ACLF (55 HBeAg-negative cases and 26 HBeAg-positive cases) who received ALSS treatment and comprehensive medical treatment. The HBeAg-negative cases and HBeAg-positive cases were compared in terms of treatment outcome and laboratory indices including alanine aminotransferase | international normalized ratio (INR) | albumin | and 0.792 | and their areas under the ROC curves were 0.875 | and INR can be used as accurate indices for prognostic evaluation of HBV-related ACLF | ObjectiveTo investigate the short-term prognosis in hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) treated with artificial liver support system (ALSS) and its relationship with clinical indices including HBeAg and to provide reference for the timely | blood ammonia
Journal Article
Journal Article
GASTROENTEROLOGY, ISSN 0016-5085, 01/2016, Volume 150, Issue 1, pp. 134 - 134
BACKGROUND & AIMS: Patients chronically infected with the hepatitis B virus rarely achieve loss of serum hepatitis B surface antigen (HBsAg) with the standard... 
Virologic Response | ENTECAVIR | PEGYLATED INTERFERON ALPHA-2A | CONTROLLED TRIAL | VIRUS | Clinical Trial | ADEFOVIR | HBSAG | NATURAL-HISTORY | LAMIVUDINE | HBeAg Seroconversion | THERAPY | TERM-FOLLOW-UP | GASTROENTEROLOGY & HEPATOLOGY | HBV
Journal Article
Journal of Virology, ISSN 0022-538X, 01/2019, Volume 93, Issue 2
Journal Article
Journal of Hepatology, ISSN 0168-8278, 11/2018, Volume 69, Issue 5, pp. 1204 - 1205
Journal Article
Gastroenterology, ISSN 0016-5085, 01/2018, Volume 154, Issue 1, pp. 20 - 22
Journal Article
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, ISSN 1590-8658, 07/2019
Seroconversion of hepatitis B e antigen (HBeAg) is a critical event in the natural course of hepatitis B virus (HBV) infection. We herein characterize the... 
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 05/2019, Volume 26, Issue 5, pp. 568 - 575
Summary The discrimination between active chronic hepatitis B (CHB) and the clinically quiescent infection (CIB) is not always easy, as a significant portion... 
chronic hepatitis B | HBsAg serum levels | HBeAg‐negative infection | HBcrAg serum levels | HBeAg-negative infection | CHRONIC HBV | INFECTIOUS DISEASES | VIRUS-INFECTION | MANAGEMENT | HBSAG | NATURAL-HISTORY | VIROLOGY | DNA | SURFACE-ANTIGEN | GASTROENTEROLOGY & HEPATOLOGY | INACTIVE CARRIERS | EPIDEMIOLOGY | Antigens | Hepatitis B
Journal Article
JOURNAL OF HEPATOLOGY, ISSN 0168-8278, 06/2013, Volume 58, Issue 6, pp. 1089 - 1095
Background 8,2 Aims: Little is currently known about the association between serum HBsAg or HBV DNA levels and the severity of liver disease in chronic... 
ALPHA-2A | Viral hepatitis | INTERFERON | Diagnostics | HBeAg | HBV DNA | RISK | HBSAG | Serum biomarkers | NATURAL-HISTORY | GASTROENTEROLOGY & HEPATOLOGY | Natural history
Journal Article
Annals of Gastroenterology, ISSN 1108-7471, 10/2018, Volume 31, Issue 6, pp. 712 - 721
Peginterferon alfa-2a induces durable responses in some hepatitis B e antigen-negative patients, but robust pretreatment predictors are not available to... 
HBsAg | Treatment | HBeAg | Virological response | Predictors | treatment | virological response | Original
Journal Article
International journal of epidemiology, ISSN 0300-5771, 12/2018, Volume 47, Issue 6, pp. 2094 - 2095
Journal Article
Journal Article
Turkish Journal of Gastroenterology, ISSN 1300-4948, 2013, Volume 24, Issue 3, pp. 230 - 240
Journal Article